Scientists from Harvard University & Mayo Clinic validate our ionic liquid platform
Ionic liquid formulation uniformly delivers chemotherapy to tumors while destroying cancerous tissue
Biotech Startup Announces R&D Collaboration With Major Japanese Drug Delivery Company
Emerging biotech company expands to HSC
Getting under the skin of psoriasis
Biotech Startup Discovers Novel Hand Sanitizer for COVID-19, Offering Long-lasting 4+ Hours of Protection
Copyright © 2020 CAGE Bio Inc. - All Rights Reserved.
Scientists from Harvard University and Mayo Clinic validate our ionic liquid platform for treating large hepatocellular tumors to help bridge more patients to liver transplantation.